Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors.
Wallace, M.B., Adams, M.E., Kanouni, T., Mol, C.D., Dougan, D.R., Feher, V.A., O'Connell, S.M., Shi, L., Halkowycz, P., Dong, Q.(2010) Bioorg Med Chem Lett 20: 4156-4158
- PubMed: 20621728 
- DOI: https://doi.org/10.1016/j.bmcl.2010.05.058
- Primary Citation of Related Structures:  
3MBL - PubMed Abstract: 
A novel series of pyrrole inhibitors of MEK kinase has been developed using structure-based drug design. Optimization of the series led to the identification of potent inhibitors with good pharmaceutical properties.
Organizational Affiliation: 
Takeda San Diego, 10410 Science Center Drive, San Diego, CA 92121, United States. michael.wallace@takedasd.com